Prognostic and immunotherapeutic significance of NCAPD2 in pan-cancer and its role in hepatocellular carcinoma progression via the AKT/GSK-3β signaling pathway
Abstract Present studies indicated that NCAPD2 (Non-SMC condensin I complex subunit D2) has emerged as an essential participant of condensin I involved in the mitotic chromosome assembly and dissociation. However, its comprehensive role in pan-cancer and its underlying mechanisms remain underexplore...
Saved in:
| Main Authors: | Wenjing Ma, Yao Tian, Wanbo Shen, Zhengrui Song, Bo Yang, Daosheng Zhou, Daowen Ye |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-96654-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of PDGFB
by: Bai Y, et al.
Published: (2025-01-01) -
NCAPD3 contributes to lung cancer progression through modulated lactate-induced histone lactylation and MEK/ERK/LDHA axis
by: Zhibo Chang
Published: (2025-05-01) -
NCAPD3 is involved in papillary thyroid carcinoma proliferation, metastasis, and aerobic glycolytic pathway
by: Liubing Zhang, et al.
Published: (2025-05-01) -
CYFIP2: potential pancreatic cancer biomarker and immunotherapeutic target
by: Cong Xiao, et al.
Published: (2024-12-01) -
Exploring the potential value of SRC in pan cancer based on bioinformatics methods
by: Liyin Huang, et al.
Published: (2025-07-01)